SEEDi1.0-3.0 strategies for major noncommunicable diseases in China

doi:10.1016/S2095-4964(17)60355-8

Abstract

The purpose of this article is to briefly introduce the status and challenges of major noncommunicable diseases (mNCDs), which include cardiovascular disease, diabetes and cancer, as well as related risk factors, such as environmental pollution, smoking, obesity and sleep disorders. “S-E-E-D” rules or the strategies of “S-E-E-D” intervention (SEEDi) consist of four core healthy elements: sleep, emotion, exercise and diet. The history of SEEDi^1.0-3.0 is also introduced, which includes versions 1.0, 1.5, 2.0 and 3.0 of the program. These guidelines are suitable for prevention and control of mNCDs. Not only the “Healthy China” initiated in China's “13th Five-year Plan,” but also the “Healthy World” philosophy needs SEEDi^1.0-3.0 strategies for control of mNCDs.

Key words: Noncommunicable diseases, Cardiovascular disease, Diabetes mellitus, Cancer, Lifestyle

Chun-song Hu, Tengiz Tkebuchava. SEEDi^1.0-3.0 strategies for major noncommunicable diseases in China. Journal of Integrative Medicine, 2017, 15(4): 265-269.

/ / Recommend

Add to citation manager EndNote| Reference Manager|ProCite|BibTeX|RefWorks

URL: http://www.jcimjournal.com/EN/10.1016/S2095-4964(17)60355-8

http://www.jcimjournal.com/EN/Y2017/V15/I4/265

TrendMD

References

1 1 World Health Organization. World health statistics 2016: monitoring health for the SDGs. (2017) [2017-01-07]. 2017) [2017-01-07]. http://www.who.int/gho/publications/world_health_ statistics/2016/en/.
2 Chen WW, Gao RL, Liu LS, Zhu ML, Wang W, Wang YJ, Wu ZS, Li HJ, Gu DF, Yang YJ, Zheng Z, Jiang LX, Hu SS.China cardiovascular diseases report 2015: a summary.J Geriatr Cardiol. 2017; 14(1): 1-10.
3 Xu Y, Wang L, He J, Bi Y, Li M, Wang T, Wang L, Jiang Y, Dai M, Lu J, Xu M, Li Y, Hu N, Li J, Mi S, Chen CS, Li G, Mu Y, Zhao J, Kong L, Chen J, Lai S, Wang W, Zhao W, Ning G; 2010 China Noncommunicable Disease Surveillance Group. Prevalence and control of diabetes in Chinese adults.JAMA. 2013; 310(9): 948-959.
4 Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J.Cancer statistics in China, 2015.CA Cancer J Clin. 2016; 66(2): 115-132.
5 GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.BD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.Lancet. 2015; 385(9963): 117-171.
6 6 World Health Organization. Environment behind nearly quarter of global deaths. (2016-03-16) [2017-01-07]. . Environment behind nearly quarter of global deaths. (2016-03-16) [2017-01-07]. http:// www.egyptindependent.com/environment-behind-nearlyquarter- global-deaths-who/.
7 Nan Y, Xi Z, Yang Y, Wang LL, Tu M, Wang JJ, Jiang Y.The 2015 China adult survey: exposure to secondhand smoke among adults aged 15 and above and their support to policy on banning smoking in public places.Chin J Epidemiol. 2016; 37(6): 810-815.
8 NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1 698 population-based measurement studies with 19.2 million participants.Lancet. 2016; 387(10026): 1377-1396.
9 Wang W, Hu SS, Kong LZ, Gao RL, Zhu ML, Wang WY, Wu ZS, Chen WW, Yang JG, Ma LY, Liu MB; Editorial Board.Summary of report on cardiovascular diseases in China, 2012.Biomed Environ Sci. 2014; 27(7): 552-558.
10 NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants.Lancet. 2016; 387(10027): 1513-1530.
11 Hu CS, Wu QH, Hu DY.Cardiovascular, diabetes, and cancer strips: evidences, mechanisms, and classifications.J Thorac Dis. 2014; 6(9): 1319-1328.
12 Koene RJ, Prizment AE, Blaes A, Konety SH.Shared risk factors in cardiovascular disease and cancer.Circulation. 2016; 133(11): 1104-1114.
13 Hu CS.RT-ABCDE strategy for management and prevention of human diseases.Chin J Integr Med. 2008; 14(2): 147-150.
14 Hu CS, Wu Q.Health: a dream from reality to the future.Front Med. 2016; 10(2): 233-235.
15 Hu CS, Han YL, Ge JB, Wu QH, Liu YN, Ma CS, Tkebuchava T, Hu DY.A novel management program for hypertension.Cardiovasc Diagn Ther. 2015; 5(4): 316-322.
16 Hu CS, Tkebuchava T.New “P” in medical model.Chin Med J (Engl). 2016; 129(4): 492-493.
17 Tan J, Li N, Gao J, Guo Y, Hu W, Yang J, Yu B, Yu J, Du W, Zhang W, Cui L, Wang Q, Xia X, Li J, Zhou P, Zhang B, Liu Z, Zhang S, Sun L, Liu N, Deng R, Dai W, Yi F, Chen W, Zhang Y, Xue S, Cui B, Zhao Y, Wang L.Construction of the Chinese Veteran Clinical Research (CVCR) platform for the assessment of non-communicable diseases.Chin Med J (Engl). 2014; 127(3): 448-456.
18 Hu C.SEEDi: Basic strategies for the primary and secondary prevention of atherosclerotic cardiovascular disease.Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2017; 42(5): 575-580.
19 Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD; Clinical Guidelines Committee of the American College of Physicians. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians.Ann Intern Med. 2016; 165(2): 125-133.
20 David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA, Biddinger SB, Dutton RJ, Turnbaugh PJ.Diet rapidly and reproducibly alters the human gut microbiome.Nature. 2014; 505(7484): 559-563.
21 Zhernakova A, Kurilshikov A, Bonder MJ, Tigchelaar EF, Schirmer M, Vatanen T, Mujagic Z, Vila AV, Falony G, Vieira-Silva S, Wang J, Imhann F, Brandsma E, Jankipersadsing SA, Joossens M, Cenit MC, Deelen P, Swertz MA; LifeLines cohort study, Weersma RK, Feskens EJ, Netea MG, Gevers D, Jonkers D, Franke L, Aulchenko YS, Huttenhower C, Raes J, Hofker MH, Xavier RJ, Wijmenga C, Fu J. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity.Science. 2016; 352(6285): 565-569.
22 Falony G, Joossens M, Vieira-Silva S, Wang J, Darzi Y, Faust K, Kurilshikov A, Bonder MJ, Valles-Colomer M, Vandeputte D, Tito RY, Chaffron S, Rymenans L, Verspecht C, De Sutter L, Lima-Mendez G, D’hoe K, Jonckheere K, Homola D, Garcia R, Tigchelaar EF, Eeckhaudt L, Fu J, Henckaerts L, Zhernakova A, Wijmenga C, Raes J.Population-level analysis of gut microbiome variation.Science. 2016; 352(6285): 560-564.
23 Du H, Li L, Bennett D, Guo Y, Key TJ, Bian Z, Sherliker P, Gao H, Chen Y, Yang L, Chen J, Wang S, Du R, Su H, Collins R, Peto R, Chen Z; China Kadoorie Biobank Study. Fresh fruit consumption and major cardiovascular disease in China.N Engl J Med. 2016; 374(14): 1332-1343.
24 Wu S, Powers S, Zhu W, Hannun YA.Substantial contribution of extrinsic risk factors to cancer development.Nature. 2016; 529(7584): 43-47.
25 Hu CS, Tkebuchava T.Structure-editing: a new branch?Chin Med J (Engl). 2016; 129(13): 1629-1630.
26 McCarthy M. US president endorses “moonshot” effort to cure cancer.BMJ. 2016; 352: i213.
27 Kaiser J, Couzin-Frankel J. BIOMEDICAL RESEARCH.Biden seeks clear course for his cancer moonshot.Science. 2016; 351(6271): 325-326.
28 Horwitz RI.Equity in cancer care and outcomes of treatment: a different type of cancer moonshot.JAMA. 2016; 315(12): 1231-1232.
29 Stevens W, Peneva D, Li JZ, Liu LZ, Liu G, Gao R, Lakdawalla DN.Estimating the future burden of cardiovascular disease and the value of lipid and blood pressure control therapies in China.BMC Health Serv Res. 2016; 16: 175.
30 Obama B.United States health care reform: progress to date and next steps.JAMA. 2016; 316(5): 525-532.
31 Zang QQ, Zhang L, Gao N, Huang C.Ophiopogonin D inhibits cell proliferation, causes cell cycle arrest at G2/M, and induces apoptosis in human breast carcinoma MCF-7 cells.J Integr Med. 2016; 14(1): 51-59.

Related Articles 15

[1]	Theocharis Koufakis, Kalliopi Kotsa, Nikolaos Papanas. Remission of type 2 diabetes depends on prompt comprehensive lifestyle changes upon diagnosis: How can this “Road to Damascus” experience be supported?. Journal of Integrative Medicine, 2022, 20(4): 288-291.
[2]	Shang-jin Song, Xuan Liu, Qing Ji, Da-zhi Sun, Li-juan Xiu, Jing-yu Xu, Xiao-qiang Yue. Ziyin Huatan Recipe, a Chinese herbal compound, inhibits migration and invasion of gastric cancer by upregulating RUNX3 expression. Journal of Integrative Medicine, 2022, 20(4): 355-364.
[3]	Jing Hong, Xiao-wan Xu, Jing Yang, Jing Zheng, Shu-mei Dai, Ju Zhou, Qing-mei Zhang, Yi Ruan, Chang-quan Ling. Knowledge about, attitude and acceptance towards, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China: A cross-sectional survey. Journal of Integrative Medicine, 2022, 20(1): 34-44.
[4]	Ofer Baranovitch, Meirav Wolff-Bar, Meora Feinmesser, Chen Sade-Zaltz, Ilan Tsarfaty, Victoria Neiman. Searching for the emotional roots of breast cancer: A cross-disciplinary analysis integrating psychology, Chinese medicine, and oncology biomarkers. Journal of Integrative Medicine, 2022, 20(1): 57-64.
[5]	Jia-jia Li, Qing Liang, Guang-chun Sun. Traditional Chinese medicine for prevention and treatment of hepatocellular carcinoma: A focus on epithelial-mesenchymal transition. Journal of Integrative Medicine, 2021, 19(6): 469-477.
[6]	Gai Ran, Xi-lin Feng, Yi-lin Xie, Qing-yun Zheng, Peng-peng Guo, Ming Yang, Ying-lu Feng, Chen Ling, Li-qing Zhu, Chen Zhong. The use of miR122 and its target sequence in adeno-associated virus-mediated trichosanthin gene therapy. Journal of Integrative Medicine, 2021, 19(6): 515-525.
[7]	Hao Gou, Ruo-chen Huang, Yong-hua Su, Wei Li. Design of dual targeting immunomicelles loaded with bufalin and study of their anti-tumor effect on liver cancer. Journal of Integrative Medicine, 2021, 19(5): 408-417.
[8]	Liang Ding, Xin-you Zhang, Di-yao Wu, Meng-ling Liu. Application of an extreme learning machine network with particle swarm optimization in syndrome classification of primary liver cancer. Journal of Integrative Medicine, 2021, 19(5): 395-407.
[9]	Eric Wei Chiang Chan, Siu Kuin Wong, Hung Tuck Chan. An overview on the chemistry, pharmacology and anticancer properties of tetrandrine and fangchinoline (alkaloids) from Stephania tetrandra roots. Journal of Integrative Medicine, 2021, 19(4): 311-316.
[10]	Ning Zhang, Xiao-he Xiao. Integrative medicine in the era of cancer immunotherapy: Challenges and opportunities. Journal of Integrative Medicine, 2021, 19(4): 291-294.
[11]	Yunita Sari, Akhyarul Anam, Annas Sumeru, Eman Sutrisna. The knowledge, attitude, practice and predictors of complementary and alternative medicine use among type 2 diabetes mellitus patients in Indonesia. Journal of Integrative Medicine, 2021, 19(4): 347-353.
[12]	Yue-jiao Shi, Hua-xian Zheng, Zhu-ping Hong, Han-bo Wang, Ying Wang, Ming-yan Li, Zhen-hao Li. Antitumor effects of different Ganoderma lucidum spore powder in cell- and zebrafish-based bioassays. Journal of Integrative Medicine, 2021, 19(2): 177-184.
[13]	Dastan M. Khoshnaw, Abhijit A. Ghadge. Yoga as a complementary therapy for metabolic syndrome: A narrative review. Journal of Integrative Medicine, 2021, 19(1): 6-12.
[14]	Pukar Khanal, Basanagouda M. Patil. Integration of network and experimental pharmacology to decipher the antidiabetic action of Duranta repens L.. Journal of Integrative Medicine, 2021, 19(1): 66-77.
[15]	Li-qing Zhu, Li Zhang, Jia Zhang, Guo-lin Chang, Gang Liu, Dan-dan Yu, Xiao-min Yu, Mi-sheng Zhao, Bin Ye. Evodiamine inhibits high-fat diet-induced colitis-associated cancer in mice through regulating the gut microbiota. Journal of Integrative Medicine, 2021, 19(1): 56-65.

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed

Comments

Recommended 10

[1]	Wei-xiong Liang. Problems-solving strategies in clinical treatment guideline for traditional Chinese medicine and integrative medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 1-4
[2]	Zhao-guo Li. Discussion on English translation of commonly used sentences in traditional Chinese medicine: part one. Journal of Chinese Integrative Medicine, 2008, 6(1): 107-110
[3]	Jun Hu, Jian-ping Liu. Non-invasive physical treatments for chronic/recurrent headache. Journal of Chinese Integrative Medicine, 2008, 6(1): 31
[4]	Xue-mei Liu, Qi-fu Huang, Yun-ling Zhang, Jin-li Lou, Hong-sheng Liu, Hong Zheng. Effects of Tribulus terrestris L. saponion on apoptosis of cortical neurons induced by hypoxia-reoxygenation in rats. Journal of Chinese Integrative Medicine, 2008, 6(1): 45-50
[5]	. Uniform requirements for manuscripts submitted to biomedical journals: Writing and editing for biomedical publication (Chinese version, part two). Journal of Chinese Integrative Medicine, 2010, 8(11): 1001-1005
[6]	Daniel Weber, Janelle M Wheat, Geoffrey M Currie. Inflammation and cancer: Tumor initiation, progression and metastasis,and Chinese botanical medicines. Journal of Chinese Integrative Medicine, 2010, 8(11): 1006-1013
[7]	Hong Liu , Guo-liang Zhang, Li Shen , Zhen Zeng, Bao-luo Zhou, Cheng-hai Liu, Guang Nie . Application and evaluation of a pseudotyped virus assay for screening herbs for anti-H5Nl avian influenza virus. Journal of Chinese Integrative Medicine, 2010, 8(11): 1036-1040
[8]	Zhao-guo Li . A discussion of English translation of 1995 and 1997 Chinese National Standards of Traditional Chinese Medical Terminologies for Clinical Diagnosis and Treatment. Journal of Chinese Integrative Medicine, 2010, 8(11): 1090-1096
[9]	Rui Jin, Bing Zhang. A complexity analysis of Chinese herbal property theory: the multiple formations of herbal property (Part 1). Journal of Chinese Integrative Medicine, 2012, 10(11): 1198-1205
[10]	Hui-min Liu, Xian-bo Wang, Yu-juan Chang, Li-li Gu. Systematic review and meta-analysis of randomized controlled trials of integrative medicine therapy for treatment of chronic severe hepatitis. Journal of Chinese Integrative Medicine, 2012, 10(11): 1211-1228